GLTO Galecto, Inc.: Operatsion rentabellik

GLTO (Galecto Corporation) - kompaniyaning tovar belgisi

Galecto, Inc. (GLTO) saraton va fibrotik patologiyalar uchun terapiya vositalarini ishlab chiqadi va hozirda barqaror daromad keltirmaydi. Operatsion marja tendentsiyasi ushbu holatni tasdiqlaydi, chunki qiymat 0.00 darajasida barqarorlashgan. Daromadning yo'qligi va aktivlarning likvidatsiya qilinishi xavfi kompaniyani narxlarni belgilash imkoniyatidan mahrum qiladi. Biroq, patent himoyasi va metabolik buzilishlarni davolash uchun yangi galektin inhibitorlari tufayli potensial imkoniyatlar saqlanib qolmoqda.

GLTO: galecto.com Operatsion foyda bo'yicha marjinallik 04.07.2022 - 10.03.2026

Galecto, Inc. (GLTO) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- narx va narxlar bo'yicha konsensus prognoz:
Kompaniyaning fundamental tahlili:Galecto Corporation, GLTO
Galecto Corporation asosiy tovari

Operatsion marja xarajatlarni boshqarish samaradorligini o'lchaydi va moliyaviy xarajatlar hamda soliqlarni hisobga olishdan oldin asosiy faoliyatdan olingan foyda ulushini ko'rsatadi. Operatsion foyda marjasi koeffitsientini tahlil qilish orqali investor Galecto (GLTO) selektiv galektin inhibitorlariga bo'lgan elastik bo'lmagan talab qanday qilib real pul oqimiga aylanishini ko'rishi mumkin, bu esa kapital barqarorligini va aktivning uzoq muddatli investitsiya jozibadorligini belgilaydi.

Raqobatdosh kompaniyalar tahlili

Operatsion rentabellik Ascendis|Madrigal Corp (MDGL) - Operatsion faoliyat rentabelligi|Operatsion rentabellik corcept.com (CORT)|Sotuvning operatsion marjasi rhythmtx.com RYTM|Operatsion marja AKRO (akerotx.com)|MTSR - Sotuvning operatsion marjasi|MLTX - Operatsion rentabellik|Operatsion foyda normasi CRNX (Crinetics Pharma)|NAMS (newamsterdampharma.com) - Sotuvning operatsion marjasi|SLNO (Soleno Therapeutics) - Operatsion rentabellik|FOLD (Amicus Therapeutics Inc) - Operatsion marja|Sotuvning operatsion rentabelligi 89bio Corp ETNB|Operatsion rentabellik Agios Corp (AGIO)|Sotuvning operatsion marjasi Structure Therapeutics GPCR|MiMedx - Sotuvning operatsion marjasi|Operatsion marja Rezolute RZLT|LXRX - Operatsion rentabellik|Operatsion faoliyat rentabelligi MBX Biosciences MBX|ALT: Operatsion marja|Aardvark Therapeutics Inc (AARD) - Operatsion marja|SGMT (Sagimet Biosciences) - Operatsion marja|Operatsion marja BioAge Labs, Inc.|Operatsion rentabellik Biomea Fusion Inc (BMEA)|QNCX - Sotuvning operatsion rentabelligi|Operatsion marja GUTS (Fractyl Health Inc.)|vtvtherapeutics.com (VTVT) - Sotuvning operatsion rentabelligi|ATPC - Operatsion rentabellik|PLUR: Operatsion rentabellik|SYBX (Synlogic, Inc.) - Sotuvning operatsion marjasi|LPCN - Operatsion faoliyat rentabelligi|MTNB (Matinas BioPharma Holdings Inc.) - Operatsion marja|Sotuvning operatsion rentabelligi Spruce Biosciences Inc. SPRB|Operatsion marja CTCX|Lumos Pharma, Inc. - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion marja ONVO (organovo.com)|Operatsion foyda bo'yicha marjinallik Radius Health